Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017 (2017), Article ID 1728456, 12 pages
https://doi.org/10.1155/2017/1728456
Research Article

Phylogenetic Diversity in Core Region of Hepatitis C Virus Genotype 1a as a Factor Associated with Fibrosis Severity in HIV-1-Coinfected Patients

1Instituto de Investigaciones Biomédicas en Retrovirus y Sida (INBIRS), Facultad de Medicina, Universidad de Buenos Aires, Paraguay 2155, Piso 11, C1121ABG Buenos Aires, Argentina
2Laboratorio de Virología y Genética Molecular (LVGM), Facultad de Ciencias Naturales y Ciencias de la Salud Sede Trelew, Universidad Nacional de la Patagonia San Juan Bosco, 9 de Julio y Belgrano S/N, Chubut, 9100 Trelew, Argentina
3Consejo Nacional de Investigaciones Científicas y Técnicas, Av. Rivadavia 1917, C1083ACA Buenos Aires, Argentina

Correspondence should be addressed to Jorge Quarleri; ra.abu.demf@irelrauq

Received 8 August 2017; Accepted 19 October 2017; Published 12 November 2017

Academic Editor: Fumio Imazeki

Copyright © 2017 Micaela Parra et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Gower, C. C. Estes, S. Hindman, K. Razavi-Shearer, and H. Razavi, “Global epidemiology and genotype distribution of the hepatitis C virus,” Journal of Hepatology, 2014. View at Publisher · View at Google Scholar
  2. L. N. Clausen, L. F. Lundbo, and T. Benfield, “Hepatitis C virus infection in the human immunodeficiency virus infected patient,” World Journal of Gastroenterology, vol. 20, no. 34, pp. 12132–12143, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Fischer, T. Baumert, and H. E. Blum, “Hepatitis C virus infection and apoptosis,” World Journal of Gastroenterology, vol. 13, no. 36, pp. 4865–4872, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Kralj, L. V. Jukić, S. Stojsavljević, M. Duvnjak, M. Smolić, and I. B. Čurčić, “Hepatitis C virus, insulin resistance, and steatosis,” Journal of Clinical and Translational Hepatology, vol. 4, no. 1, pp. 66–75, 2016. View at Publisher · View at Google Scholar
  5. S. Blackham, A. Baillie, F. Al-Hababi et al., “Gene expression profiling indicates the roles of host oxidative stress, apoptosis, lipid metabolism, and intracellular transport genes in the replication of hepatitis C virus,” Journal of Virology, vol. 84, no. 10, pp. 5404–5414, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Banerjee, R. B. Ray, and R. Ray, “Oncogenic potential of hepatitis C virus proteins,” Viruses, vol. 2, no. 9, pp. 2108–2133, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. L. B. Seeff, “Natural history of chronic hepatitis C,” Hepatology, vol. 36, no. 5, pp. S35–S46, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. J. M. Miro, P. Stock, E. Teicher, J.-C. Duclos-Vallée, N. Terrault, and A. Rimola, “Outcome and management of HCV/HIV coinfection pre- and post-liver transplantation. A 2015 update,” Journal of Hepatology, vol. 62, no. 3, pp. 701–711, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Domingo, J. Sheldon, and C. Perales, “Viral quasispecies evolution,” Microbiology and Molecular Biology Reviews, vol. 76, no. 2, pp. 159–216, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. C. C. Kao, G. Yi, and H. Huang, “The core of hepatitis C virus pathogenesis,” Current Opinion in Virology, vol. 17, pp. 66–73, 2016. View at Publisher · View at Google Scholar
  11. N. Akuta, F. Suzuki, Y. Kawamura et al., “Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis,” Hepatology, vol. 46, no. 5, pp. 1357–1364, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Akuta, F. Suzuki, Y. Seko et al., “Complicated relationships of amino acid substitution in hepatitis C virus core region and IL28B genotype influencing hepatocarcinogenesis,” Hepatology, vol. 56, no. 6, pp. 2134–2141, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Seko, N. Akuta, F. Suzuki et al., “Amino acid substitutions in the hepatitis C virus core region and lipid metabolism are associated with hepatocarcinogenesis in nonresponders to interferon plus ribavirin combination therapy,” Intervirology, vol. 56, no. 1, pp. 13–21, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Barreiro, L. Martín-Carbonero, M. Núñez et al., “Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: Assessment using transient elastometry and the role of HCV genotype 3,” Clinical Infectious Diseases, vol. 42, no. 7, pp. 1032–1039, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. M.-A. Loko, L. Castera, F. Dabis et al., “Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine Cohort,” American Journal of Gastroenterology, vol. 103, no. 8, pp. 1973–1980, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Matas, A. Picornell, C. Cifuentes et al., “Relating the liver damage with hepatitis C virus polymorphism in core region and human variables in HIV-1-coinfected patients,” Infection, Genetics and Evolution, vol. 10, no. 8, pp. 1252–1261, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Matas, A. Picornell, C. Cifuentes et al., “Generalized Linear Model (GLM) framework for the association of host variables and viral strains with liver fibrosis in HCV/HIV coinfected patients,” Infection, Genetics and Evolution, vol. 13, no. 1, pp. 284–291, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Bedossa, D. Dargère, and V. Paradis, “Sampling variability of liver fibrosis in chronic hepatitis C,” Hepatology, vol. 38, no. 6, pp. 1449–1457, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. EASL., “EASL Clinical Practice Guidelines: management of hepatitis C virus infection,” Hepatol, vol. 55, pp. 245–264, 2011. View at Google Scholar
  20. D. J. T. Bruden, B. J. McMahon, L. Townshend-Bulson et al., “Risk of end stage liver disease, hepatocellular carcinoma, and liver-related death by fibrosis stage in the hepatitis C Alaska Cohort,” Hepatology, 2017. View at Google Scholar
  21. J. A. Cepeda, D. L. Thomas, J. Astemborski, M. S. Sulkowski, G. D. Kirk, and S. H. Mehta, “Increased Mortality Among Persons With Chronic Hepatitis C With Moderate or Severe Liver Disease: A Cohort Study,” Clinical Infectious Diseases, vol. 65, no. 2, pp. 235–243, 2017. View at Publisher · View at Google Scholar
  22. K. Katoh and D. M. Standley, “MAFFT: Iterative refinement and additional methods,” Methods in Molecular Biology, vol. 1079, pp. 131–146, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. M. N. Price, P. S. Dehal, and A. P. Arkin, “FastTree 2—approximately maximum-likelihood trees for large alignments,” PLoS ONE, vol. 5, no. 3, Article ID e9490, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Felsenstein, “PHYLIP (Phylogeny Inference Package) version 3.6,” pp. 164–166, 2005. View at Google Scholar
  25. D. H. Huson and C. Scornavacca, “Dendroscope 3: An interactive tool for rooted phylogenetic trees and networks,” Systematic Biology, vol. 61, no. 6, pp. 1061–1067, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. T. J. Wheeler, J. Clements, and R. D. Finn, “Skylign: A tool for creating informative, interactive logos representing sequence alignments and profile hidden Markov models,” BMC Bioinformatics, vol. 15, no. 1, article no. 7, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. D. P. Faith, “Conservation evaluation and phylogenetic diversity,” Biological Conservation, vol. 61, no. 1, pp. 1–10, 1992. View at Publisher · View at Google Scholar · View at Scopus
  28. S. W. Kembel, P. D. Cowan, M. R. Helmus et al., “Picante: R tools for integrating phylogenies and ecology,” Bioinformatics, vol. 26, no. 11, pp. 1463-1464, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. D. A. Nipperess, “The Rarefaction of Phylogenetic Diversity: Formulation, Extension and Application,” in Biodiversity Conservation and Phylogenetic Systematics, vol. 14 of Topics in Biodiversity and Conservation, pp. 197–217, Springer International Publishing, Cham, 2016. View at Publisher · View at Google Scholar
  30. B. T. M. Korber, K. MacInnes, R. F. Smith, and G. Myers, “Mutational trends in V3 loop protein sequences observed in different genetic lineages of human immunodeficiency virus type 1,” Journal of Virology, vol. 68, no. 10, pp. 6730–6744, 1994. View at Google Scholar · View at Scopus
  31. S. L. Kosakovsky Pond and S. D. W. Frost, “Not so different after all: a comparison of methods for detecting amino acid sites under selection,” Molecular Biology and Evolution, vol. 22, no. 5, pp. 1208–1222, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. B. Murrell, J. O. Wertheim, S. Moola, T. Weighill, K. Scheffler, and S. L. Kosakovsky Pond, “Detecting individual sites subject to episodic diversifying selection,” PLoS Genetics, vol. 8, no. 7, Article ID e1002764, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. S. L. Kosakovsky Pond, S. D. W. Frost, and S. V. Muse, “HyPhy: Hypothesis testing using phylogenies,” Bioinformatics, vol. 21, no. 5, pp. 676–679, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. W. Delport, A. F. Y. Poon, S. D. W. Frost, and S. L. Kosakovsky Pond, “Datamonkey 2010: A suite of phylogenetic analysis tools for evolutionary biology,” Bioinformatics, vol. 26, no. 19, Article ID btq429, pp. 2455–2457, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. S. L. Kosakovsky Pond and S. D. W. Frost, “Datamonkey: rapid detection of selective pressure on individual sites of codon alignments,” Bioinformatics, vol. 21, no. 10, pp. 2531–2533, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Sede, L. R. Jones, F. Moretti, N. Laufer, and J. Quarleri, “Corrigendum to "Inter and intra-host variability of hepatitis C virus genotype 1a hypervariable envelope coding domains followed for a 4-11 year of human immunodeficiency virus coinfection and highly active antiretroviral therapy" [Virology 471-473 (2014) 19-28],” Virology, vol. 474, pp. 199-200, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Sede, M. Parra, J. M. Manrique, N. Laufer, L. R. Jones, and J. Quarleri, “Evolution of hepatitis C virus in HIV coinfected patients under antiretroviral therapy,” Infection, Genetics and Evolution, vol. 43, pp. 186–196, 2016. View at Publisher · View at Google Scholar · View at Scopus
  38. A. El-Shamy, M. Pendleton, F. J. Eng, E. H. Doyle, A. Bashir, and A. D. Branch, “Impact of HCV core gene quasispecies on hepatocellular carcinoma risk among HALT-C trial patients,” Scientific Reports, vol. 6, Article ID 27025, 2016. View at Publisher · View at Google Scholar · View at Scopus
  39. W. M. Ezzat and K. S. Amr, “Insights for hepatitis C virus related hepatocellular carcinoma genetic biomarkers: Early diagnosis and therapeutic intervention,” World Journal of Hepatology, vol. 8, no. 30, pp. 1251–1261, 2016. View at Publisher · View at Google Scholar · View at Scopus
  40. S. L. Fishman, S. H. Factor, C. Balestrieri et al., “Mutations in the hepatitis C virus core gene are associated with advanced liver disease and hepatocellular carcinoma,” Clinical Cancer Research, vol. 15, no. 9, pp. 3205–3213, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. F. S. Alhamlan, M. N. Al-Ahdal, N. Z. Khalaf et al., “Hepatitis C virus genotype 1: How genetic variability of the core protein affects the response to pegylated-interferon and ribavirin therapy,” Journal of Medical Virology, vol. 86, no. 2, pp. 224–234, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. J. McLauchlan, “Properties of the hepatitis C virus core protein: A structural protein that modulates cellular processes,” Journal of Viral Hepatitis, vol. 7, no. 1, pp. 2–14, 2000. View at Publisher · View at Google Scholar · View at Scopus
  43. R. B. Ray and R. Ray, “Hepatitis C virus core protein: Intriguing properties and functional relevance,” FEMS Microbiology Letters, vol. 202, no. 2, pp. 149–156, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. B. de Chassey, V. Navratil, L. Tafforeau et al., “Hepatitis C virus infection protein network,” Molecular Systems Biology, vol. 4, no. 1, article 230, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. M. R. Higgs, H. Lerat, and J.-M. Pawlotsky, “Hepatitis C virus-induced activation of β-catenin promotes c-Myc expression and a cascade of pro-carcinogenetic events,” Oncogene, vol. 32, no. 39, pp. 4683–4693, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. F. Kurbanov, Y. Tanaka, K. Matsuura et al., “Positive selection of core 70Q variant genotype 1b hepatitis C virus strains induced by pegylated interferon and ribavirin,” The Journal of Infectious Diseases, vol. 201, no. 11, pp. 1663–1671, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. L. Cuypers, G. Li, P. Libin, S. Piampongsant, A.-M. Vandamme, and K. Theys, “Genetic diversity and selective pressure in hepatitis C virus genotypes 1–6: significance for direct-acting antiviral treatment and drug resistance,” Viruses, vol. 7, no. 9, pp. 5018–5039, 2015. View at Publisher · View at Google Scholar · View at Scopus
  48. E. Alestig, B. Arnholm, A. Eilard et al., “Core mutations, IL28B polymorphisms and response to peginterferon/ribavirin treatment in Swedish patients with hepatitis C virus genotype 1 infection,” BMC Infectious Diseases, vol. 11, article no. 124, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. R. C. Jaspe, Y. F. Sulbarán, M. Z. Sulbarán, C. L. Loureiro, H. R. Rangel, and F. H. Pujol, “Prevalence of amino acid mutations in hepatitis C virus core and NS5B regions among Venezuelan viral isolates and comparison with worldwide isolates,” Virology Journal, vol. 9, article no. 214, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. D. Kadjbaf, M. Keshvari, S. M. Alavian et al., “The prevalence of hepatitis C virus core amino acid 70 substitution and genotypes of polymorphisms near the IFNL3 gene in iranian patients with chronic hepatitis C,” Hepatitis Monthly, vol. 16, no. 6, Article ID e37011, 2016. View at Publisher · View at Google Scholar · View at Scopus
  51. N. Echeverría, G. Moratorio, J. Cristina, and P. Moreno, “Hepatitis C virus genetic variability and evolution,” World Journal of Hepatology, vol. 7, no. 6, pp. 831–845, 2015. View at Publisher · View at Google Scholar · View at Scopus
  52. C. Bittar, A. C. G. Jardim, L. H. T. Yamasaki et al., “On Hepatitis C Virus Evolution: The Interaction between Virus and Host towards Treatment Outcome,” PLoS ONE, vol. 8, no. 4, Article ID e62393, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. J. Cristina, M. D. P. Moreno, and G. Moratorio, “Hepatitis C virus genetic variability in patients undergoing antiviral therapy,” Virus Research, vol. 127, no. 2, pp. 185–194, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. E. Aparicio, S. Franco, M. Parera et al., “Complexity and catalytic efficiency of hepatitis C virus (HCV) NS3 and NS4A protease quasispecies influence responsiveness to treatment with pegylated interferon plus ribavirin in HCV/HIV-coinfected patients,” Journal of Virology, vol. 85, no. 12, pp. 5961–5969, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. D. Ge, J. Fellay, A. J. Thompson et al., “Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance,” Nature, vol. 461, no. 7262, pp. 399–401, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. M. H. Nguyen and E. B. Keeffe, “Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6,” Clinical Gastroenterology and Hepatology, vol. 3, no. 2, pp. S97–S101, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. M. Duffy, M. Salemi, N. Sheehy et al., “Comparative rates of nucleotide sequence variation in the hypervariable region of E1/E2 and the NS5b region of hepatitis C virus in patients with a spectrum of liver disease resulting from a common source of infection,” Virology, vol. 301, no. 2, pp. 354–364, 2002. View at Publisher · View at Google Scholar · View at Scopus
  58. P. Farci, I. Quinti, S. Farci et al., “Evolution of hepatitis C viral quasispecies and hepatic injury in perinatally infected children followed prospectively,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 103, no. 22, pp. 8475–8480, 2006. View at Publisher · View at Google Scholar · View at Scopus
  59. D. G. Sullivan, D. Bruden, H. Deubner et al., “Hepatitis C virus dynamics during natural infection are associated with long-term histological outcome of chronic hepatitis C disease,” The Journal of Infectious Diseases, vol. 196, no. 2, pp. 239–248, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. H. Qin, N. J. Shire, E. D. Keenan et al., “HCV quasispecies evolution: Association with progression to end-stage liver disease in hemophiliacs infected with HCV or HCV/HIV,” Blood, vol. 105, no. 2, pp. 533–541, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. J. I. Arenas, J. F. Gallegos-Orozco, T. Laskus et al., “Hepatitis C virus quasi-species dynamics predict progression of fibrosis after liver transplantation,” The Journal of Infectious Diseases, vol. 189, no. 11, pp. 2037–2046, 2004. View at Publisher · View at Google Scholar · View at Scopus
  62. A. C. Lyra, X. Fan, D. M. Lang et al., “Evolution of hepatitis C viral quasispecies after liver transplantation,” Gastroenterology, vol. 123, no. 5, pp. 1485–1493, 2002. View at Publisher · View at Google Scholar · View at Scopus
  63. D. Harouaka, R. E. Engle, K. Wollenberg et al., “Diminished viral replication and compartmentalization of hepatitis C virus in hepatocellular carcinoma tissue,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 113, no. 5, pp. 1375–1380, 2016. View at Publisher · View at Google Scholar · View at Scopus